Wolfgang Jagla

Title: Wolfgang Jagla: Innovator in Transgenic Mouse Models

Introduction

Wolfgang Jagla is a prominent inventor based in Windach, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of transgenic mouse models. His work focuses on understanding and addressing diseases related to Aβ peptide overexpression.

Latest Patents

Wolfgang Jagla holds a patent for "Transgenic mouse models of Aβ overexpression." This patent describes a transgenic non-human animal, specifically a transgenic mouse, that encodes Aβ peptide proteins. These proteins have been implicated in diseases related to Aβ peptide. The patent also includes cells and cell lines that comprise transgenes encoding for Aβ peptide. Furthermore, it outlines methods and compositions for evaluating agents that affect Aβ peptide, which can be used in treatments for Aβ peptide-related diseases. He has 1 patent to his name.

Career Highlights

Wolfgang Jagla is associated with Probiodrug AG, a company that focuses on innovative solutions in the field of drug development. His work at Probiodrug AG has been instrumental in advancing research related to Aβ peptide and its implications in various diseases.

Collaborations

Wolfgang has collaborated with notable colleagues, including Stephan Schilling and Holger Cynis. These collaborations have further enriched his research and contributed to the advancements in the understanding of Aβ peptide-related diseases.

Conclusion

Wolfgang Jagla's innovative work in transgenic mouse models has paved the way for new insights into Aβ peptide-related diseases. His contributions to biotechnology continue to have a significant impact on the field.